To address this paradox, we proposed the hypothesis that Irs1-mediated insulin signalling is enhanced, whereas Irs2-mediated insulin signalling is impaired in the liver in type 2 diabetes and obesity. The gene discussed is IRS2; the disease is obesity disorder.